St. Jude Medical CEO Dan Starks is bullish on the potential for recent acquisition CardioMEMS to tap the $1 billion market for treating heart failure.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qCvjeU
Cap comentari:
Publica un comentari a l'entrada